ALTERITY THERAPEUTICS LTD's ticker is ATHE and the CUSIP is 02155X106. A total of 10 filers reported holding ALTERITY THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $182,584 | -24.2% | 524,364 | -4.1% | 0.00% | – |
| Q3 2022 | $241,000 | -33.8% | 546,964 | -8.1% | 0.00% | – |
| Q2 2022 | $364,000 | -24.3% | 595,264 | +2.6% | 0.00% | – |
| Q1 2022 | $481,000 | +19.4% | 579,964 | +3.6% | 0.00% | – |
| Q4 2021 | $403,000 | -44.3% | 559,864 | -1.6% | 0.00% | – |
| Q3 2021 | $723,000 | -11.5% | 568,964 | -9.4% | 0.00% | – |
| Q2 2021 | $817,000 | -9.6% | 628,261 | +0.1% | 0.00% | – |
| Q1 2021 | $904,000 | +15.9% | 627,907 | +7.9% | 0.00% | – |
| Q4 2020 | $780,000 | -13.4% | 582,097 | +30.5% | 0.00% | – |
| Q3 2020 | $901,000 | +78.1% | 445,978 | +4.8% | 0.00% | – |
| Q2 2020 | $506,000 | +197.6% | 425,497 | +50.3% | 0.00% | – |
| Q1 2020 | $170,000 | -17.1% | 283,097 | +7.6% | 0.00% | – |
| Q4 2019 | $205,000 | -24.9% | 263,000 | +9.7% | 0.00% | – |
| Q3 2019 | $273,000 | -8.7% | 239,822 | +5.1% | 0.00% | – |
| Q2 2019 | $299,000 | – | 228,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OLD MISSION CAPITAL LLC | 12,707 | $17,000 | 0.00% |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 1,065 | $1,000 | 0.00% |
| UBS Group AG | 6,339 | $8,000 | 0.00% |
| NEXT Financial Group, Inc | 583 | $1,000 | 0.00% |
| Advisor Group, Inc. | 2,500 | $3,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 500 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,128 | $16,000 | 0.00% |
| MORGAN STANLEY | 228,200 | $299,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,451 | $15,000 | 0.00% |